Companies researching Veklury (remdesivir)
Veklury, the brand name for the antiviral drug remdesivir developed by Gilead Sciences, is given by intravenous injection and is authorized for use in specific COVID‑19 patients.
6
companies
List of companies that research Veklury (remdesivir)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
 United States | Biotechnology Research | 15k | $27B | Veklury (remdesivir) | |
 United Kingdom | Higher Education | 2.2k | $3B | Veklury (remdesivir) | |
 France | Research Services | 23k | $675M | Veklury (remdesivir) | |
United States | Higher Education | 17k | Veklury (remdesivir) |
Showing top companies out of 6 that research Veklury (remdesivir). Get the full list on TheirStack.
Frequently asked questions